Versant Venture Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
GGHC
NAMA
Versant Venture Management's VCYT Position: Q3 2020 in Review
Versant Venture Management sold out of Veracyte (VCYT) in Q3 2020, closing a stake of 1,205,407 shares — an estimated $31.2M sold.
Versant Venture Management first reported a position in VCYT in Q3 2018 and held it in 8 quarters. The position peaked at $90.5M in Q1 2019. 189 funds tracked by Wall St. Rank hold VCYT as of Q3 2020.
- Versant Venture Management reported no remaining Veracyte position as of Q3 2020 after selling out during the quarter.
- Versant Venture Management sold 1,205,407 Veracyte shares in Q3 2020, an estimated $31.2M.
- Versant Venture Management first reported a position in Veracyte in Q3 2018 and held it in 8 quarters.
- Versant Venture Management's Veracyte position peaked at $90.5M in Q1 2019.
- 189 funds tracked by Wall St. Rank held Veracyte as of Q3 2020.
Based on Versant Venture Management's 13F filing for Q3 2020, filed 12 Nov 2020.